Pfizer is formally submitting the application on Friday...the review process is expected to take a few weeks. If approved, the first Americans could receive the vaccine by mid-December.
“The antiviral drug remdesivir is not suggested for patients admitted to hospital with Covid-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival..."